Package 68682-301-30
Brand: pyridostigmine bromide
Generic: pyridostigmine bromidePackage Facts
Identity
Package NDC
68682-301-30
Digits Only
6868230130
Product NDC
68682-301
Description
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68682-301-30)
Marketing
Marketing Status
Brand
pyridostigmine bromide
Generic
pyridostigmine bromide
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4823269e-594b-4f83-99ce-e9d2436bc5f1", "openfda": {"unii": ["KVI301NA53"], "rxcui": ["903847"], "spl_set_id": ["7cf12f6c-4c6c-474b-895a-93151d657ca6"], "manufacturer_name": ["Oceanside Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68682-301-30)", "package_ndc": "68682-301-30", "marketing_start_date": "19590112"}], "brand_name": "pyridostigmine bromide", "product_id": "68682-301_4823269e-594b-4f83-99ce-e9d2436bc5f1", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "68682-301", "generic_name": "pyridostigmine bromide", "labeler_name": "Oceanside Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "pyridostigmine bromide", "active_ingredients": [{"name": "PYRIDOSTIGMINE BROMIDE", "strength": "180 mg/1"}], "application_number": "NDA011665", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "19590112", "listing_expiration_date": "20261231"}